BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12039920)

  • 1. Thalidomide in solid malignancies.
    Eisen T
    J Clin Oncol; 2002 Jun; 20(11):2607-9. PubMed ID: 12039920
    [No Abstract]   [Full Text] [Related]  

  • 2. Thalidomide in solid tumours: the resurrection of an old drug.
    Sleijfer S; Kruit WH; Stoter G
    Eur J Cancer; 2004 Nov; 40(16):2377-82. PubMed ID: 15519508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thalidomide. Clinical trials in cancer].
    Politi PM
    Medicina (B Aires); 2000; 60 Suppl 2():61-5. PubMed ID: 11188934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide in small cell lung cancer: wrong drug or wrong disease?
    Rüegg C; Peters S
    J Natl Cancer Inst; 2009 Aug; 101(15):1034-5. PubMed ID: 19608998
    [No Abstract]   [Full Text] [Related]  

  • 5. Thalidomid: current role in the treatment of non-plasma cell malignancies.
    Kumar S; Witzig TE; Rajkumar SV
    J Clin Oncol; 2004 Jun; 22(12):2477-88. PubMed ID: 15197211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide in Kaposi sarcoma: promising or disappointing?
    Laffitte E
    Dermatology; 2007; 215(3):171-2. PubMed ID: 17823510
    [No Abstract]   [Full Text] [Related]  

  • 7. Thalidomide in cancer medicine.
    Eleutherakis-Papaiakovou V; Bamias A; Dimopoulos MA
    Ann Oncol; 2004 Aug; 15(8):1151-60. PubMed ID: 15277253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide: present and future in multiple myeloma.
    Hussein MA
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):25-31. PubMed ID: 15757435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of thalidomide and its IMiD derivatives as anticancer agents.
    Bartlett JB; Dredge K; Dalgleish AG
    Nat Rev Cancer; 2004 Apr; 4(4):314-22. PubMed ID: 15057291
    [No Abstract]   [Full Text] [Related]  

  • 10. Current status of thalidomide in the treatment of cancer.
    Rajkumar SV
    Oncology (Williston Park); 2001 Jul; 15(7):867-74; discussion 877-9. PubMed ID: 11499688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide in the treatment of cancer.
    Adlard JW
    Anticancer Drugs; 2000 Nov; 11(10):787-91. PubMed ID: 11142686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic renaissance of thalidomide in the treatment of haematological malignancies.
    Ribatti D; Vacca A
    Leukemia; 2005 Sep; 19(9):1525-31. PubMed ID: 15973447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thalidomide--new prospective therapy in oncology].
    Pałgan K; Pałgan I
    Wiad Lek; 2003; 56(9-10):455-9. PubMed ID: 15049211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide treatment attenuates chemotherapy-induced gonadal toxicity.
    Ochalski ME; Shuttleworth JJ; Chu T; Orwig KE
    Fertil Steril; 2011 Feb; 95(2):819-22. PubMed ID: 20889152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies.
    Gilheeney SW; Lyden DC; Sgouros S; Antunes N; Gerald W; Kramer K; Lis E; Meyers P; Rosen N; Thaler HT; Trippett T; Wexler L; Dunkel IJ
    Pediatr Blood Cancer; 2007 Sep; 49(3):261-5. PubMed ID: 16972243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective analysis of thalidomide therapy in non-HIV-related Kaposi's sarcoma.
    Ben M'barek L; Fardet L; Mebazaa A; Thervet E; Biet I; Kérob D; Morel P; Lebbe C
    Dermatology; 2007; 215(3):202-5. PubMed ID: 17823515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials referral resource. Current clinical trials of thalidomide.
    Streicher HZ; Vereshchagina LA; Schoenfeldt M
    Oncology (Williston Park); 2003 Mar; 17(3):369-71, 374-5, 379-80. PubMed ID: 12661268
    [No Abstract]   [Full Text] [Related]  

  • 18. Thalidomide in multiple myeloma.
    Rajkumar SV
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 13):11-6. PubMed ID: 11204667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelial cells as a therapeutic marker for thalidomide in combined therapy with chemotherapy drugs in a human prostate cancer model.
    Li H; Raia V; Bertolini F; Price DK; Figg WD
    BJU Int; 2008 Apr; 101(7):884-8. PubMed ID: 18070197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma.
    Arrieta O; Guevara P; Tamariz J; Rembao D; Rivera E; Sotelo J
    Int J Exp Pathol; 2002 Apr; 83(2):99-104. PubMed ID: 12084046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.